Today's Low
₹ 461.25
Today's High
₹ 559.80
52 Weeks Low
₹ 320.00
52 Weeks High
₹ 495.00
Lower
₹ 379.05
Upper
₹ 568.55
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and profiling. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
---|---|---|---|---|---|---|
Total Current Assets | 1,187.5 | 1,239.3 | 1,057.6 | 672.0 | 648.1 | 607.8 |
Total Non-Current Assets | 1,633.2 | 1,650.5 | 1,530.3 | 1,481.4 | 1,311.9 | 1,213.7 |
Total Assets | 2,820.7 | 2,889.8 | 2,588.0 | 2,153.4 | 1,960.0 | 1,821.5 |
Total Current Liabilities | 1,101.1 | 1,063.4 | 788.7 | 729.9 | 655.5 | 738.0 |
Total Non-Current Liabilities | 217.1 | 299.2 | 206.5 | 333.3 | 344.2 | 315.1 |
Shareholder's Funds | 1,500.2 | 1,524.9 | 1,588.5 | 1,085.9 | 955.9 | 764.0 |
Total Liabilities | 2,820.7 | 2,889.8 | 2,588.0 | 2,153.4 | 1,960.0 | 1,821.5 |
The Industry Price to BV stands at 6.08, vs the Price to BV of 1.44, which results in a Negative aspect.
The Industry Current Ratio stands at 2.31, vs the Current Ratio of 0.92, which results in a Negative aspect.
The Industry Quick Ratio stands at 1.60, vs the Quick Ratio of 0.54, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.22, vs the Debt to Equity Ratio of 0.72, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
---|---|---|---|---|---|---|
Total Income | 1,443.8 | 1,268.4 | 1,616.9 | 1,321.8 | 1,408.6 | 560.4 |
Total Expenditure | 1,309.9 | 1,188.4 | 1,231.0 | 1,062.3 | 1,197.0 | 500.8 |
Operating Profit(Excl OI) | 156.4 | 100.0 | 414.6 | 287.0 | 223.9 | 62.1 |
Add: Other Income | 22.6 | 20.0 | 28.8 | 27.5 | 12.4 | 2.5 |
Operating Profit | 156.4 | 100.0 | 414.6 | 287.0 | 223.9 | 62.1 |
Less: Interest | 90.1 | 75.3 | 84.5 | 77.9 | 82.5 | 25.2 |
PBDT | 66.4 | 24.7 | 330.2 | 209.1 | 141.5 | 36.9 |
Less: Depreciation Amortization | 111.2 | 112.3 | 108.7 | 94.2 | 83.7 | 36.7 |
PBT & Exceptional Items | -44.8 | -87.6 | 221.5 | 114.9 | 57.8 | 0.2 |
Less: Exceptional Income Expenses | 0.0 | -3.5 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | -44.8 | -91.1 | 221.5 | 114.9 | 57.8 | 0.2 |
Less: Taxation | -22.6 | -32.8 | 0.2 | 0.4 | -1.7 | -0.1 |
Profit After Tax | -22.3 | -58.3 | 221.4 | 114.5 | 59.4 | 0.3 |
Earnings Per Share | -6.2 | -16.2 | 61.6 | 42.7 | 23.1 | 0.0 |
The Industry PE Ratio stands at 43.11, vs the PE Ratio of 0.00, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.59, vs the Dividend Yield of 0.00, which results in a Negative aspect.
The Industry PAT Margin stands at 9.73, vs the PAT Margin of 8.66, which results in a Negative aspect.
The Industry PAT Growth stands at 32.10, vs the PAT Growth of 70.70, which results in a Positive aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
---|---|---|---|---|---|---|
Profit Before Tax | -44.8 | -91.1 | 221.5 | 114.9 | 57.8 | 0.2 |
Tax Paid | 13.5 | -18.1 | -33.4 | -24.3 | -14.4 | -2.9 |
Adjustment | 186.8 | 181.0 | 173.2 | 168.0 | 148.3 | 62.8 |
Changes In Working Capital | -44.8 | -91.1 | 221.5 | 114.9 | 57.8 | 0.2 |
Cash Flow after changes in Working Capital | 142.7 | -223.9 | 188.8 | 266.5 | 180.7 | 52.1 |
Cash Flow from Operating Activities | 156.3 | -242.0 | 155.5 | 242.2 | 166.3 | 49.2 |
Cash Flow from Investing Activities | -81.1 | -242.9 | -106.3 | -358.8 | -115.7 | -85.5 |
Cash Flow from Financing Activities | -112.8 | 333.6 | 92.5 | 97.0 | -23.4 | 67.7 |
Net Cash Inflow / Outflow | -37.7 | -151.3 | 141.7 | -19.7 | 27.3 | 31.5 |
Opening Cash & Cash Equivalents | 46.4 | 197.7 | 56.0 | 75.7 | 46.0 | 0.0 |
Closing Cash & Cash Equivalent | 8.7 | 46.4 | 197.7 | 56.0 | 75.7 | 46.0 |
The Industry PCF RATIO stands at 24.27, vs the PCF RATIO of 4.91, which results in a Negative aspect.
The Industry PFCF Ratio stands at 25.12, vs the PFCF Ratio of -15.79, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 2,487.3 | 4,252.4 | 3,523.1 | 3,806.2 | 3,947.5 | 3,383.7 | 3,300.7 | 3,608.2 | 1,003.4 | 4,016.1 | 4,055.7 | 4,442.1 | 4,266.9 | 3,975.6 | 3,484.2 | 2,967.7 |
Total Income | 2,491.8 | 4,264.2 | 3,543.5 | 3,853.0 | 4,019.2 | 3,420.9 | 3,370.5 | 3,668.9 | 1,050.7 | 4,049.2 | 4,114.8 | 4,539.9 | 4,349.8 | 4,036.8 | 3,530.0 | 3,089.0 |
Total Expenditure | 4,104.2 | 3,876.1 | 3,331.9 | 3,318.5 | 3,497.5 | 3,108.0 | 3,175.2 | 3,472.9 | 1,971.8 | 3,297.5 | 3,141.5 | 3,451.0 | 3,213.5 | 2,999.4 | 2,646.2 | 2,466.9 |
PBIDT (Excl OI) | -1,616.9 | 376.3 | 191.2 | 487.7 | 450.0 | 275.7 | 125.5 | 135.3 | -968.4 | 718.6 | 914.2 | 991.1 | 1,053.4 | 976.2 | 838.0 | 500.8 |
Other Income | 4.5 | 11.8 | 20.4 | 46.8 | 71.7 | 37.2 | 69.8 | 60.7 | 47.3 | 33.1 | 59.1 | 97.8 | 82.9 | 61.2 | 45.8 | 121.3 |
Operating Profit | -1,612.4 | 388.1 | 211.6 | 534.5 | 521.7 | 312.9 | 195.3 | 196.0 | -921.1 | 751.7 | 973.3 | 1,088.9 | 1,136.3 | 1,037.4 | 883.8 | 622.1 |
Interest | 253.7 | 244.4 | 246.1 | 219.6 | 236.4 | 219.6 | 225.0 | 214.7 | 178.2 | 170.3 | 189.6 | 248.3 | 204.5 | 193.7 | 198.3 | 203.8 |
Exceptional Items | -627.7 | -52.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -13.1 | -15.2 | -0.8 | -5.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | -2,493.8 | 91.5 | -34.5 | 314.9 | 285.3 | 93.3 | -29.7 | -31.8 | -1,114.5 | 580.6 | 777.9 | 840.6 | 931.8 | 843.7 | 685.5 | 418.3 |
Depreciation | 259.6 | 262.1 | 259.1 | 264.5 | 279.8 | 286.3 | 281.3 | 278.2 | 284.4 | 283.8 | 276.8 | 274.4 | 273.9 | 276.0 | 262.3 | 239.3 |
Profit Before Tax | -2,753.4 | -170.6 | -293.6 | 50.4 | 5.5 | -193.0 | -311.0 | -310.0 | -1,398.9 | 296.8 | 501.1 | 566.2 | 657.9 | 567.7 | 423.2 | 179.0 |
Tax | 0.0 | 0.0 | -102.5 | 12.8 | 1.2 | -93.2 | -146.5 | -328.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.8 | 0.5 | 0.9 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | -2,753.4 | -170.6 | -191.1 | 37.6 | 4.3 | -99.8 | -164.5 | 18.1 | -1,398.9 | 296.8 | 501.1 | 566.1 | 657.8 | 566.9 | 422.7 | 178.1 |
Net Profit | -2,753.4 | -170.6 | -191.1 | 37.6 | 4.3 | -99.8 | -164.5 | 18.1 | -1,398.9 | 296.8 | 501.1 | 566.1 | 657.8 | 566.9 | 422.7 | 178.1 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 360.0 | 360.0 | 360.0 | 360.0 | 360.0 | 360.0 | 360.0 | 360.0 | 359.4 | 359.2 | 359.2 | 359.2 | 358.2 | 358.2 | 268.6 | 268.6 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | -76.5 | -4.8 | -5.4 | 1.1 | 0.1 | -2.8 | -4.6 | 0.5 | -38.9 | 8.3 | 14.0 | 15.6 | 18.5 | 19.2 | 15.8 | 6.8 |
Operating Profit Margin | -64.8 | 9.1 | 6.0 | 14.0 | 13.2 | 9.2 | 5.9 | 5.4 | -91.8 | 18.7 | 24.0 | 24.5 | 26.6 | 26.1 | 25.4 | 21.0 |
Net Profit Margin | -110.7 | -4.0 | -5.4 | 1.0 | 0.1 | -2.9 | -5.0 | 0.5 | -139.4 | 7.4 | 12.4 | 12.7 | 15.4 | 14.3 | 12.1 | 6.0 |
The Industry Net Sales Growth stands at 11.07, vs the Net Sales Growth of -4.68, which results in a Negative aspect.
The Industry Mcap Growth stands at 19.65, vs the Mcap Growth of 10.19, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 748.85 | 826.79 | 605.95 |
R3 | 685.83 | 699.58 | 578.85 |
R2 | 622.82 | 629.69 | 569.82 |
R1 | 587.28 | 601.03 | 560.78 |
Pivot | 524.27 | 531.14 | 524.27 |
S1 | 488.73 | 502.48 | 542.72 |
S2 | 425.72 | 432.59 | 533.68 |
S3 | 390.18 | 403.93 | 524.65 |
S4 | 354.65 | 235.49 | 497.55 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
100.00
Bearish
RSI
62.91
Neutral
ROC
33.32
Bullish
UltimateOscillator
70.75
Bullish
Williams Indicator
-4.24
Bearish
CCI Indicator
239.76
Bearish
MACD
-2,604.15
Bearish
Stochastic Indicator
91.57
Neutral
ATR
27.81
Low Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
18-08-2021 | 3.00 | 30 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
14-02-2024 | Quarterly Results |
14-11-2023 | Quarterly Results |
14-08-2023 | Quarterly Results (Revised) |
11-08-2023 | Quarterly Results |
05-07-2023 | Right Issue of Equity Shares |
12-05-2023 | Audited Results |
25-01-2023 | Quarterly Results |
09-11-2022 | Quarterly Results |
04-08-2022 | Quarterly Results |
29-04-2022 | Dividend & Audited Results |
09-02-2022 | Quarterly Results |
11-11-2021 | Quarterly Results |
04-08-2021 | Quarterly Results |
06-05-2021 | Dividend & Audited Results |